Show Notes
Gregory Ostrow, MD, joins Jennifer Galvin, MD, to discuss his entrepreneurism in pediatric ophthalmology and the starting of Sydnexis, a clinical-stage biopharmaceutical company he founded. He describes the journey to discovering a way to neutralize and stabilize compounded atropine eye drops to effectively treat myopia in pediatric patients. He also shares information from the STAR study, a phase 3 clinical trial evaluating the company's patented formulation of low-dose atropine for myopia control.
More from Little Eyes, Big Topics
Celebrating 50 episodes of Little Eyes, Big Topics!
How is AI shaping children's vision care?
Inspiring the next generation of pediatric eye care leaders! In this new episode of Little Eyes, Big Topics, co-hosts Erin Capper, MD, and Meghan Hunt, MD, sit down with expert guest Dr. Pavlina S. Kemp for an engaging conversation about keeping residents excited about pediatric ophthalmology!
In the latest Little Eyes, Big Topics, co-host John Morse, MPH and expert guest Dr. Julius Oatts break down the Pediatric Ophthalmology Mentorship (POM) Program.